Statement of Ownership (sc 13g)

Date : 09/27/2019 @ 3:18PM
Source : Edgar (US Regulatory)
Stock : Cytori Therapeutics Inc (CYTX)
Quote : 0.2077  0.0 (0.00%) @ 12:00AM

Statement of Ownership (sc 13g)

 

 

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

 

SCHEDULE 13G

(Rule 13d-102)

(Amendment No.     )

INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO

RULES 13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED

PURSUANT TO RULE 13d-2(b)

 

 

Plus Therapeutics, Inc.

(Name of Issuer)

Common Stock, par value $0.001 per share

(Title of Class of Securities)

72941H400

(CUSIP Number)

September 23, 2019

(Date of Event Which Requires Filing of this Statement)

 

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

☒ Rule 13d-1(b)

☐ Rule 13d-1(c)

☐ Rule 13d-1(d)

 

 

 


   

CUSIP No. 72941H400

 

   13G     

 

  1   

NAME OF REPORTING PERSONS

I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)

 

Anson Funds Management LP

  2  

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

(a)  ☐        (b)  ☐

 

  3    

SEC USE ONLY

 

  4  

CITIZENSHIP OR PLACE OF ORGANIZATION

 

Texas

 NUMBER OF 

 SHARES 

 BENEFICIALLY 

 OWNED BY 

 EACH 

 REPORTING 

 PERSON 

 WITH 

   5     

SOLE VOTING POWER

 

0

   6   

SHARED VOTING POWER

 

369,379

   7   

SOLE DISPOSITIVE POWER

 

0

   8   

SHARED DISPOSITIVE POWER

 

369,379

  9    

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

369,379

10  

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*

 

11  

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

 

9.9% **

12  

TYPE OF REPORTING PERSON*

 

IA, PN

 

*

SEE INSTRUCTIONS BEFORE FILLING OUT

**

SEE ITEM 4(b).

 

2


   

CUSIP No. 72941H400

 

   13G     

 

  1   

NAME OF REPORTING PERSONS

I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)

 

Anson Management GP LLC

  2  

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

(a)  ☐        (b)  ☐

 

  3    

SEC USE ONLY

 

  4  

CITIZENSHIP OR PLACE OF ORGANIZATION

 

Texas

 NUMBER OF 

 SHARES 

 BENEFICIALLY 

 OWNED BY 

 EACH 

 REPORTING 

 PERSON 

 WITH 

   5     

SOLE VOTING POWER

 

0

   6   

SHARED VOTING POWER

 

369,379

   7   

SOLE DISPOSITIVE POWER

 

0

   8   

SHARED DISPOSITIVE POWER

 

369,379

  9    

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

369,379

10  

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*

 

11  

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

 

9.9% **

12  

TYPE OF REPORTING PERSON*

 

HC, OO

 

*

SEE INSTRUCTIONS BEFORE FILLING OUT

**

SEE ITEM 4(b).

 

3


   

CUSIP No. 72941H400

 

   13G     

 

  1   

NAME OF REPORTING PERSONS

I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)

 

Bruce R. Winson

  2  

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

(a)  ☐        (b)  ☐

 

  3    

SEC USE ONLY

 

  4  

CITIZENSHIP OR PLACE OF ORGANIZATION

 

United States Citizen

 NUMBER OF 

 SHARES 

 BENEFICIALLY 

 OWNED BY 

 EACH 

 REPORTING 

 PERSON 

 WITH 

   5     

SOLE VOTING POWER

 

0

   6   

SHARED VOTING POWER

 

369,379

   7   

SOLE DISPOSITIVE POWER

 

0

   8   

SHARED DISPOSITIVE POWER

 

369,379

  9    

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

369,379

10  

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*

 

11  

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

 

9.9% **

12  

TYPE OF REPORTING PERSON*

 

HC, IN

 

*

SEE INSTRUCTIONS BEFORE FILLING OUT

**

SEE ITEM 4(b).

 

4


   

CUSIP No. 72941H400

 

   13G     

 

  1   

NAME OF REPORTING PERSONS

I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)

 

Anson Advisors Inc.

  2  

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

(a)  ☐        (b)  ☐

 

  3    

SEC USE ONLY

 

  4  

CITIZENSHIP OR PLACE OF ORGANIZATION

 

Ontario, Canada

 NUMBER OF 

 SHARES 

 BENEFICIALLY 

 OWNED BY 

 EACH 

 REPORTING 

 PERSON 

 WITH 

   5     

SOLE VOTING POWER

 

0

   6   

SHARED VOTING POWER

 

369,379

   7   

SOLE DISPOSITIVE POWER

 

0

   8   

SHARED DISPOSITIVE POWER

 

369,379

  9    

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

369,379

10  

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*

 

11  

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

 

9.9% **

12  

TYPE OF REPORTING PERSON*

 

FI, CO

 

*

SEE INSTRUCTIONS BEFORE FILLING OUT

**

SEE ITEM 4(b).

 

5


   

CUSIP No. 72941H400

 

   13G     

 

  1   

NAME OF REPORTING PERSONS

I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)

 

Amin Nathoo

  2  

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

(a)  ☐        (b)  ☐

 

  3    

SEC USE ONLY

 

  4  

CITIZENSHIP OR PLACE OF ORGANIZATION

 

Canadian Citizen

 NUMBER OF 

 SHARES 

 BENEFICIALLY 

 OWNED BY 

 EACH 

 REPORTING 

 PERSON 

 WITH 

   5     

SOLE VOTING POWER

 

0

   6   

SHARED VOTING POWER

 

369,379

   7   

SOLE DISPOSITIVE POWER

 

0

   8   

SHARED DISPOSITIVE POWER

 

369,379

  9    

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

369,379

10  

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*

 

11  

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

 

9.9% **

12  

TYPE OF REPORTING PERSON*

 

HC, IN

 

*

SEE INSTRUCTIONS BEFORE FILLING OUT

**

SEE ITEM 4(b).

 

6


   

CUSIP No. 72941H400

 

   13G     

 

  1   

NAME OF REPORTING PERSONS

I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)

 

Moez Kassam

  2  

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

(a)  ☐        (b)  ☐

 

  3    

SEC USE ONLY

 

  4  

CITIZENSHIP OR PLACE OF ORGANIZATION

 

Canadian Citizen

 NUMBER OF 

 SHARES 

 BENEFICIALLY 

 OWNED BY 

 EACH 

 REPORTING 

 PERSON 

 WITH 

   5     

SOLE VOTING POWER

 

0

   6   

SHARED VOTING POWER

 

369,379

   7   

SOLE DISPOSITIVE POWER

 

0

   8   

SHARED DISPOSITIVE POWER

 

369,379

  9    

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

369,379

10  

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*

 

11  

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

 

9.9% **

12  

TYPE OF REPORTING PERSON*

 

HC, IN

 

*

SEE INSTRUCTIONS BEFORE FILLING OUT

**

SEE ITEM 4(b).

 

7


SCHEDULE 13G

This Schedule 13G (the “Schedule 13G”) is being filed on behalf of Anson Funds Management LP (d/b/a Anson Funds), a Texas limited partnership, Anson Management GP LLC, a Texas limited liability company, Mr. Bruce R. Winson, the principal of Anson Funds Management LP and Anson Management GP LLC, Anson Advisors Inc., an Ontario, Canada corporation, Mr. Amin Nathoo, a director of Anson Advisors Inc., and Mr. Moez Kassam, a director of Anson Advisors Inc., relating to Common Stock, par value $0.001 per share (the “Common Stock”), of Plus Therapeutics, Inc., a Delaware corporation (the “Issuer”).

This Schedule 13G relates to the Common Stock of the Issuer purchased by a private fund to which Anson Funds Management LP and Anson Advisors Inc. serve as co-investment advisors (the “Fund”). Anson Funds Management LP and Anson Advisors Inc. serve as co-investment advisors to the Fund and may direct the vote and disposition of the 369,379 shares of Common Stock held by the Fund. As the general partner of Anson Funds Management LP, Anson Management GP LLC may direct the vote and disposition of the 369,379 shares of Common Stock held by the Fund. As the principal of Anson Fund Management LP and Anson Management GP LLC, Mr. Winson may direct the vote and disposition of the 369,379 shares of Common Stock held by the Fund. As directors of Anson Advisors Inc., Mr. Nathoo and Mr. Kassam may each direct the vote and disposition of the 369,379 shares of Common Stock held by the Fund.

 

Item 1(a)    Name of Issuer.
   Plus Therapeutics, Inc.
Item 1(b)    Address of Issuer’s Principal Executive Offices.
   4200 Marathon Blvd., Suite 200
   Austin, TX, 78756
Item 2(a)    Name of Person Filing.
   Anson Funds Management LP, Anson Management GP LLC, Mr. Bruce R. Winson, Anson Advisors Inc., Mr. Amin Nathoo and Mr. Moez Kassam
Item 2(b)    Address of Principal Business Office, or, if none, Residence.
   For Anson Funds Management LP, Anson Management GP LLC and Mr. Winson:
   5950 Berkshire Lane, Suite 210
   Dallas, Texas 75225
   For Anson Advisors Inc., Mr. Nathoo and Mr. Kassam:
   155 University Ave, Suite 207
   Toronto, ON
   M5H 3B7

 

8


Item 2(c)    Citizenship or Place of Organization.
   Anson Funds Management LP is a limited partnership organized under the laws of the State of Texas. Anson Management GP LLC is a limited liability company organized under the laws of the State of Texas. Mr. Winson is a United States citizen. Anson Advisors Inc. is a corporation organized under the laws of Ontario, Canada. Mr. Nathoo and Mr. Kassam are each Canadian citizens.
Item 2(d)    Title of Class of Securities.
   Common Stock, par value $0.001 per share
Item 2(e)    CUSIP Number.
   72941H400
Item 3    Reporting Person.

If this statement is filed pursuant to Rule 13d-1(b), or 13d-2(b), check whether the person filing is a:

 

(a)       Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).
(b)       Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).
(c)       Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).
(d)       Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).
(e)       An investment advisor in accordance with §240.13d-1(b)(1)(ii)(E).
(f)       An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F).
(g)       A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G).
(h)       A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813).
(i)       A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3).
(j)       A non-U.S. institution that is the functional equivalent of any of the institutions listed in § 240.13d-1 (b)(1)(ii)(A) through (I), so long as the non-U.S. institution is subject to a regulatory scheme that is substantially comparable to the regulatory scheme applicable to the equivalent U.S. institution.
(k)       Group, in accordance with §240.13d-1(b)(1)(ii)(K).

 

9


Item 4    Ownership.
  

(a)   Anson Funds Management LP, Anson Management GP LLC, Mr. Winson, Anson Advisors Inc., Mr. Nathoo and Mr. Kassam are the beneficial owners of 369,379 shares of Common Stock held by the Fund. The Fund also holds: (i) pre-funded warrants relating to 302,620 shares of Common Stock which are not currently exercisable due to a beneficial ownership limitation of 9.99%; and (ii) common warrants relating to 1,710,600 shares of Common Stock which are not currently exercisable due to a beneficial ownership limitation of 4.99%.

  

(b)   Anson Funds Management LP, Anson Management GP LLC, Mr. Winson, Anson Advisors Inc., Mr. Nathoo and Mr. Kassam are the beneficial owners of 9.9% of the outstanding shares of Common Stock. This percentage is determined by dividing 369,379 by 3,697,469, which represents the shares of Common Stock issued and outstanding as of September 23, 2019, as reported in the Issuer’s prospectus filed on Form 424(b) with the Securities and Exchange Commission (the “SEC”) on September 24, 2019.

  

(c)   Anson Funds Management LP and Anson Advisors Inc., as the co-investment advisors to the Fund, may direct the vote and disposition of the 369,379 shares of Common Stock held by the Fund. Anson Management GP LLC, as the general partner of Anson Funds Management LP, may direct the vote and disposition of the 369,379 shares of Common Stock held by the Fund. As the principal of Anson Funds Management LP and Anson Management GP LLC, Mr. Winson may direct the vote and disposition of the 369,379 shares of Common Stock held by the Fund. Mr. Nathoo and Mr. Kassam, each as a director of Anson Advisors Inc., may direct the vote and disposition of the 369,379 shares of Common Stock held by the Fund.

Item 5    Ownership of Five Percent or Less of a Class.
   Inapplicable.
Item 6    Ownership of More Than Five Percent on Behalf of Another Person.
   Inapplicable.
Item 7    Identification and Classification of the Subsidiary which Acquired the Security Being Reported On by the Parent Holding Company.
   Inapplicable.
Item 8    Identification and Classification of Members of the Group.
   Inapplicable.
Item 9    Notice of Dissolution of Group.
   Inapplicable.

 

10


Item 10    Certification.
   By signing below each of the Reporting Persons certifies that, to the best of such person’s knowledge and belief, the securities referred to above were acquired and held in the ordinary course of business and were not acquired and were not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.
Exhibits    Exhibit 99.1
   Joint Filing Agreement dated September 27, 2019, by and among Anson Funds Management LP, Anson Management GP LLC, Mr. Winson, Anson Advisors Inc., Mr. Nathoo and Mr. Kassam.

 

11


SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Date: September 27, 2019

 

ANSON FUNDS MANAGEMENT LP
By: Anson Management GP LLC, its general partner
By:  

/s/ Bruce R. Winson

  Bruce R. Winson
  Manager
ANSON MANAGEMENT GP LLC
By:  

/s/ Bruce R. Winson

  Bruce R. Winson
  Manager

/s/ Bruce R. Winson

Bruce R. Winson
ANSON ADVISORS INC.
By:  

/s/ Amin Nathoo

  Amin Nathoo
  Director
By:  

/s/ Moez Kassam

  Moez Kassam
  Director

/s/ Amin Nathoo

Amin Nathoo

/s/ Moez Kassam

Moez Kassam

 

12

Cytori Therapeutics (NASDAQ:CYTX)
Historical Stock Chart

1 Year : From Nov 2018 to Nov 2019

Click Here for more Cytori Therapeutics Charts.

Cytori Therapeutics (NASDAQ:CYTX)
Intraday Stock Chart

Today : Wednesday 20 November 2019

Click Here for more Cytori Therapeutics Charts.

Latest CYTX Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.